Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial

OBJECTIVES: C-reactive protein point-of-care testing (CRP POCT) is a promising diagnostic tool to guide antibiotic prescribing for lower respiratory tract infections (LRTI) in nursing home residents. This study aimed to evaluate cost-effectiveness and return-on-investment (ROI) of CRP POCT compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Boere, Tjarda M, El Alili, Mohamed, van Buul, Laura W, Hopstaken, Rogier M, Verheij, Theo J M, Hertogh, Cees M P M, van Tulder, Maurits W, Bosmans, Judith E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478864/
https://www.ncbi.nlm.nih.gov/pubmed/36109036
http://dx.doi.org/10.1136/bmjopen-2021-055234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478864/
https://www.ncbi.nlm.nih.gov/pubmed/36109036
http://dx.doi.org/10.1136/bmjopen-2021-055234

Ejemplares similares